Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

December 19, 2007

Ustekinumab

Analysis of: Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis | www.jnj.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Jeffrey Weinberg
Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER
Implications: This drug is four times yearly This will be attractive to MDs and patients It is highly efficaciuous

Analysis: This drug can compete as a first-line option for biologic therapy in psoriasis. It appears safe and effective.  It is only 4 SQ injections yearly

Other Analyses of the Same Source Article:
Ustekinumab-new drug that gets to the core of psoriasis
December 19, 2007, Author: GLG Expert Contributor
Ustekinumab for Autoimmune Diseases
December 17, 2007, Author: GLG Expert Contributor
Centecor Ustekinumab- an impressive product for psoriasis
December 17, 2007, Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University
Centocors Ustekinumab in psoriasis
December 14, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses

Azilect
September 2, 2008

Byetta Saves Lives
September 2, 2008

The Devil Is in the Details
September 1, 2008

Dangers of Methadone Usage
August 28, 2008

Healthways A Market Downturn and Results
August 26, 2008

 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-09-06T21:45:17.077